Jennifer J Rhodes

CIK 1568249 · EVP, CHIEF LEGAL OFFICER, SEC · last filed 2026-03-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$319.0K

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$2.44M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ACAD	EVP, CHIEF LEGAL OFFICER, SEC	15,124	$21.09	$319.0K	-$245.0K	5	2026-03-26
Elicio Therapeutics, Inc. (ANGN) Delisted	See Remarks	30,399	$10.00	$304.0K	-$62.4K	15	2022-03-04
Adamas Pharmaceuticals Inc (ADMS) Delisted	CBO, GC & Compliance Officer	63,114	$8.22	$518.8K	-$106.0K	13	2019-06-21
MEDIVATION, INC. (MDVN) Delisted	GC & Corporate Secretary	11,090	—	—	-$2.03M	10	2015-03-17

Recent Filings · Page 5 of 5

43 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2014-02-20	MEDIVATION, INC. (MDVN) Delisted	Grant (A)	—	$0	EDGAR
2014-02-06	MEDIVATION, INC. (MDVN) Delisted	Grant (A)	+4,500	$0	EDGAR
2014-01-23	MEDIVATION, INC. (MDVN) Delisted	Mixed	−28,000	-$1.73M	EDGAR

Showing 41–43 of 43

Prev Page 5 of 5

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.